<?xml version="1.0" encoding="UTF-8"?>
<ref id="B112">
 <citation citation-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lingappa</surname>
    <given-names>JR</given-names>
   </name>
   <name>
    <surname>Rosenstein</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Zell</surname>
    <given-names>ER</given-names>
   </name>
   <name>
    <surname>Shutt</surname>
    <given-names>KA</given-names>
   </name>
   <name>
    <surname>Schuchat</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Perkins</surname>
    <given-names>BA</given-names>
   </name>
   <collab>Active Bacterial Core Surveillance (ABCs) Team</collab>
  </person-group>
  <article-title>Surveillance for menigococcal disease and strategies for use of conjugate meningococcal vaccines in the United States</article-title>
  <source>Vaccine</source>
  <year>2001</year>
  <volume>19</volume>
  <fpage>4566</fpage>
  <lpage>4575</lpage>
  <pub-id pub-id-type="pmid">11483285</pub-id>
  <pub-id pub-id-type="doi">10.1016/S0264-410X(01)00209-2</pub-id>
 </citation>
</ref>
